|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 263.20 USD | +2.45% |
|
+3.88% | +15.19% |
| 07-28 | Barclays Adjusts AbbVie PT to $300 From $275, Maintains Overweight Rating | MT |
| 07-27 | S&P 500 Second-Quarter Earnings Growth Reaches 70%, Oppenheimer Says | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 281.37 | 291.97 | 291.19 |
| Spread/Res. | -6.46% | -9.85% | -9.61% |
| Spread/Supp. | +15.58% | +15.58% | +15.58% |
| Support | 227.73 | 227.73 | 227.73 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ABBV Stock
- Charts AbbVie Inc.
Select your edition
All financial news and data tailored to specific country editions
